Gillian Morgan

Clinica Universidad de Navarra — Spain

Medicine · Health Sciences

15h-index1.1kcitations40works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(10), Immunotherapy and Immune Responses(5), Monoclonal and Polyclonal Antibodies Research(5), Microbial infections and disease research(5), T-cell and B-cell Immunology(4)

Publications40 total

PS1349 UPDATED RISK STRATIFICATION MODEL FOR SMOLDERING MULTIPLE MYELOMA (SMM) INCORPORATING THE REVISED IMWG DIAGNOSTIC CRITERIA
HemaSphere·2019· 1 citedOpen Access
Phase 1 Study of Elotuzumab and Peripheral Blood Mononuclear Cell Reconstitution in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma
Blood·2017
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Blood·2016· 4 cited
Phase 1 Study of Elotuzumab in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma
Blood·2016· 1 cited
Outcomes and Management of Red Blood Cell Transfusions in Multiple Myeloma Patients Treated with Daratumumab
Blood·2015· 8 cited
Recapturing Disease Response: A Phase II Study of High Dose Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma Who Have Progressed on Standard Dose Carfilzomib
Blood·2015· 3 cited
A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma
Blood·2015· 16 cited
A phase II study of panobinostat with lenalidomide and weekly dexamethasone in myeloma.
Journal of Clinical Oncology·2015· 7 cited
Overall survival of patients with relapsed and refractory multiple myeloma: adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone vs. high-dose dexamethasone
Ghent University Academic Bibliography (Ghent University)·2014· 1 cited
Evaluation of Analytical and Preliminary Clinical Performance of Myconostica MycAssay Aspergillus When Testing Serum Specimens for Diagnosis of Invasive Aspergillosis
Journal of Clinical Microbiology·2011· 82 citedOpen Access
Multicenter, Prospective Clinical Evaluation of Respiratory Samples from Subjects at Risk for Pneumocystis jirovecii Infection by Use of a Commercial Real-Time PCR Assay
Journal of Clinical Microbiology·2011· 94 citedOpen Access
Retrospective analysis of the long term safety of lenalidomide (Len)±dexamethasone (Dex) in relapsed/refractory multiple myeloma (RRMM) patients (pts): analysis of pooled data and incidence rates (IR) of second primary malignancy (SPM)
Haematologica·2011· 4 citedOpen Access
The role of cholecystokinin[A]-receptors in protein hydrolysate-induced suppressio of food intake in rats
TSpace (University of Toronto)·1998· 1 citedOpen Access
Characterization of a recombinant Onchocerca volvulus antigen (Ov33) produced in yeast.
PubMed·1997· 13 cited
Relationship Between the OKT Phenotype of Alloreactive Human T Cell Clones and Their Specificity for HLA Class II Antigens
1984
Human T cell clones allospecific for HLA‐DR5 antigen with the OKT8 phenotype
Tissue Antigens·1983· 9 cited
Antigens of the erythrocytic stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies
Molecular and Biochemical Parasitology·1983· 133 cited
Antigenic Diversity in the Human Malaria Parasite <i>Plasmodium falciparum</i>
Science·1982· 159 cited
Study of anH-2K d mutant strain: C.B6-H-2 dm4
Immunogenetics·1981· 3 cited
IMPLICATION OF THE H-2L LOCUS IN HYBRID HISTOCOMPATIBILITY (Hh-1)
Transplantation·1981· 12 cited
page 1 of 2Next →

Frequent Co-authors

Ian F. C. McKenzie(18), Roger W. Melvold(15), Hearn Jay Cho(7), Sundar Jagannath(7), Samir Parekh(7), Lisa La(6), Erika Florendo(6), Elaine Chan(6), Ajai Chari(5), Donna Catamero(5), Juliet Escalon(5), Daniel Verina(5), Mauro S. Sandrin(4), Terry A. Potter(3), H. Dellos(3), Katarzyna Garcia(3), Crystle Carter(3), Nadege Stevens(3), Moon‐hee Yum(3), Jude Gullie(3)